| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 06/03/2008 | US7381424 Hydrostatic delivery system for controlled delivery of agent |
| 06/03/2008 | US7381412 Monoclonal antibody for use in diagnosis, prevention and treatment of inflammatory disorders |
| 06/03/2008 | CA2389360C Urea derivatives as anti-inflammatory agents |
| 06/03/2008 | CA2335065C Pharmaceutical formulations for aerosols with two or more active substances |
| 05/29/2008 | WO2008063581A2 Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs |
| 05/29/2008 | WO2008063116A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | WO2008062861A1 Extract powder of indigo-containing plant, method for production thereof, and use thereof |
| 05/29/2008 | WO2008061968A1 Benzimidazolone derivates in the treatment of pulmonary arterial hypertension |
| 05/29/2008 | WO2008061740A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 05/29/2008 | WO2008061612A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 05/29/2008 | WO2008040649A3 Pyrazine-2-carboxamide derivatives as cb2 receptor modulators |
| 05/29/2008 | WO2008016123A1 GSK-3β INHIBITOR |
| 05/29/2008 | WO2007076053A8 Stable s-nitrosothiol formulations |
| 05/29/2008 | US20080125489 administering retinoic acid receptor (RAR) agonists, that promote the formation of alveolar membranes and increase gas-exchange surface in the lungs; repsiratory system disorders |
| 05/29/2008 | US20080125477 7-(acryloyl) indole compositions and methods of making and using same |
| 05/29/2008 | US20080125474 Pyrazole Analogs |
| 05/29/2008 | US20080125466 Useful in the treatment of conditions associated with pathological receptor activation; inhibiting binding of vanilloid ligand to a capsaicin receptor; (4-tert-Butyl-phenyl)-[1,1-dioxo-6-(3-trifluoromethyl-pyridin-2-yl)-1H-1?6-benzo[d]isothiazol-3-yl]-amine |
| 05/29/2008 | US20080125462 Cinnamate Salts Of A Beta-2 Adrenergic Agonist |
| 05/29/2008 | US20080125461 Treating, preventing and managing various pulmonary diseases or disorders; with a leukotriene inhibitor such as zafirlukast, montelukast |
| 05/29/2008 | US20080125453 Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions |
| 05/29/2008 | US20080125426 7-(4-Chlorophenyl)-4-morpholin-4-yl-7H-pyrrolo[2,3-d]pyrimidine-2-carbonitrile; reversible inhibitors of cysteine proteases S, K, F, L, B; diseases associated with Cathepsin S; antiinflammatory agent, autoimmune diseases; asthma, rheumatoid arthritis, multiple sclerosis, Alzheimer's and Crohn's disease |
| 05/29/2008 | US20080125419 Benzothiazole derivatives with activity as adenosine receptor ligands |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125415 Novel methods for treatment of diseases related to activated lymphocytes |
| 05/29/2008 | US20080125391 administering to a mammal harboring a tumor which expresses HALRs, a Sindbis virus vector to treat the tumor, and the vector has not been modified to target a tumor-specific cellular determinant, has a preferential affinity for HALRs, a Sindbis virus E2 HALR binding domain; ganciclovir; gene therapy |
| 05/29/2008 | US20080125375 Peptide like compounds for treating coronavirus or aviviridae virus; severe acute respiratory distress syndrome |
| 05/29/2008 | US20080125365 Fibronectins; inflammation |
| 05/29/2008 | US20080124743 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (u1) |
| 05/29/2008 | US20080124323 Using fructooligosaccharides as components of probiotics for use in prevention and treatment of infection |
| 05/29/2008 | US20080124277 Human and Mouse Targeting Peptides Identified by Phage Display |
| 05/29/2008 | CA2677335A1 Indozalyl sulphonamide derivatives useful as glucocorticoid modulators |
| 05/29/2008 | CA2670340A1 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
| 05/29/2008 | CA2670143A1 Pyrimidines and their use as cxcr2 receptor antagonists |
| 05/29/2008 | CA2669300A1 Use of arginase inhibitors in the treatment of asthma and allergic rhinitis |
| 05/29/2008 | CA2669124A1 Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity |
| 05/28/2008 | EP1925293A2 Pharmaceutical aerosol compositions |
| 05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924565A1 Diaminopyrimidines as p2x3 and p3x2/3 modulators |
| 05/28/2008 | EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924264A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1660475B1 Pyrimidylpyrrole derivatives active as kinase inhibitors |
| 05/28/2008 | EP1546098B1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1471895B1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| 05/28/2008 | EP1424326B1 Fused-polycyclic compounds |
| 05/28/2008 | EP1420020B1 4-oxoimidazolidine-2-spiropiperidine derivative |
| 05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
| 05/28/2008 | EP1368063B1 Complex of modafinil and cyclodextrin |
| 05/28/2008 | EP1344526B1 Preventives/remedies for inflammatory airway diseases |
| 05/28/2008 | EP1326630B1 Use of glp-2 peptides |
| 05/28/2008 | EP1005485B1 Therapeutic pulmonary lavage with diluted surfactants |
| 05/28/2008 | EP0854927B1 Human dnase i variants |
| 05/28/2008 | CN101186920A High-throughput diagnostic assay for the human virus causing severe acute respiratory syndrome (SARS) |
| 05/28/2008 | CN101185761A Ephedrine hydrochloride cyclodextrin inclusion compound and its granule preparation method |
| 05/28/2008 | CN101185759A Anti-angiogene compositions and methods of use |
| 05/28/2008 | CN101185740A Orally-administered traditional Chinese medicine for treating windheat attacks the lung type hematemesis |
| 05/28/2008 | CN101185725A Medicinal food capable of moistening lung and relieving asthma |
| 05/28/2008 | CN101185719A Medicinal composition for treating rhinitis and nasosinusitis |
| 05/28/2008 | CN101185707A Antiphlogistic antiviral medicinal composition, and its preparation method and application |
| 05/28/2008 | CN101185680A Collunarium medicine for treating chronic rhinitis |
| 05/28/2008 | CN101185673A Medicine for treating nasosinusitis |
| 05/28/2008 | CN101185666A Collunarium medicine for treating acute rhinitis |
| 05/28/2008 | CN101185652A Remedies for lung cancer |
| 05/28/2008 | CN101185643A Application of (E)-1-(2, 4-dihydroxy-5-(3-methyl-butyl-2-alkenyl) phenyl)-3-(4-hydroxy-phenyl) propylene-2-ketone-1 in medicine |
| 05/28/2008 | CN101185638A Microemulsion preparation and preparation method thereof |
| 05/28/2008 | CN101185509A Medicinal food for spleen-invigorating and blood-nourishing |
| 05/28/2008 | CN100390179C Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 05/28/2008 | CN100390178C Polycycloalkylpurines as adenosine receptor antagonists |
| 05/28/2008 | CN100390173C Tricyclic compound |
| 05/28/2008 | CN100390163C 2-(2,6-dioxopiperidin-3-yl)-isoindoline derivatives, their preparation and their use as inhibitors of inflammatory cytokines |
| 05/28/2008 | CN100389809C Chinese medicinal composition for treating asthma, and its preparation and use |
| 05/28/2008 | CN100389792C Pharmaceutical composition for treating nose disease and its preparation method |
| 05/28/2008 | CN100389788C Extract of perilla and its use in preparation of medicine |
| 05/28/2008 | CN100389771C Use of composition comprising Formoterol and Budesonide for prevention or treatment of acute condition of asthma |
| 05/28/2008 | CN100389766C Pharmaceutical use of dihydro myricetin |
| 05/28/2008 | CN100389757C Guaiamar dripping pill |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378526 Cholinergic ligands at the nicotinic acetylcholine receptors; diseases related to the cholinergic system; neurodegenerative disorders; pain; antiinflammatory; diagnostic or monitoring tools using labelled forms; 3-Phenyletynyl-quinuclidin-2-ene |
| 05/27/2008 | US7378525 CCR8 inhibitors |
| 05/27/2008 | US7378444 Antiinflammatory agents; cardiovascular disorders; vision disorders; skin disorders; central nervous system disorders; antiarthritic agents |
| 05/27/2008 | US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378430 inhibitors of cGMP PDE, especially Type 5; erectile dysfunction and sexual disorders; 6-Bromo-N-[(3-chloro-methoxyphenyl)methyl]-2-(2-pyridinyl)-4-quinolinamine |
| 05/27/2008 | US7378428 phosphodiesterase inhibitors; (Z)-2-(7-bromomethyl-3,3-dimethyl-3,4-dihydro-(2H)-isoquinolin-1-ylidene)-1-(adamantan-1-yl)ethan-1-one; graft versus host disease, osteoporosis, bone fracture, restenosis, arteriosclerosis, obesity, ischemic reperfusion injury, depression, allergies, transplant rejection |
| 05/27/2008 | US7378424 Derivatives of pyrimido[6, 1-A]isoquinolin-4-one |
| 05/27/2008 | US7378413 2-amino-3-(alkyl)-pyrimidone derivatives |
| 05/27/2008 | US7378403 phosphoinositol ether lipid analogues and bioisosteres thereof;serine/threonine kinase (protein kinase B (PKB)) inhibitor; antitumor and anticarcinogenic agent; decreasing phosphorylation, increasing apoptosis in a tumor cell, and inhibiting pleckstrin homology (PH) domain binding |
| 05/27/2008 | US7378393 Recombinant anticoagulant proteins |
| 05/27/2008 | CA2455115C Pharmaceutical aerosol formulation |
| 05/27/2008 | CA2423357C Fused heterocyclic derivatives as phosphodiesterase inhibitors |
| 05/22/2008 | WO2008061016A1 N-substituted piperidinyl 4 -arylsulfonamides as modulators of the secreted frizzled related protein- 1 |
| 05/22/2008 | WO2008060372A2 Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
| 05/22/2008 | WO2008060371A1 USE OF TGF-β ANTAGONISTS TO TREAT INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA |
| 05/22/2008 | WO2008059867A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059866A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059865A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 05/22/2008 | WO2008059239A1 Novel compounds 514 |
| 05/22/2008 | WO2008058968A1 Crystalline form of tiotropium bromide and urea |
| 05/22/2008 | WO2008058897A2 Diphyllin and other lignans as a medicament for v-atpase mediated disease |
| 05/22/2008 | WO2008058536A1 Novel 4-amino-pyridine derivatives and their use as potassium channel modulators |